Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.
Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.
Real-world study finds esketamine combined with an SNRI linked to lower mortality, hospitalization, and relapse rates compared to esketamine plus SSRI in treatment-resistant depression.
A large Parkinson’s study found that a decline in dopamine transporter signals in the less affected putamen tracks worsening motor symptoms, supporting the use of DaT imaging for monitoring disease progression.
New research links high levels of micronanoplastics in carotid artery plaque to stroke symptoms, suggesting a potential new target for cardiovascular disease prevention.